Quantcast

Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr Instagram
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
November 28, 2014, 10:04:21 PM

Login with username, password and session length


Members
  • Total Members: 24078
  • Latest: Rlhayn
Stats
  • Total Posts: 647772
  • Total Topics: 49368
  • Online Today: 210
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online
Users: 5
Guests: 122
Total: 127

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Here comes Vir201 !  (Read 1094 times)

0 Members and 1 Guest are viewing this topic.

Offline hahaha

  • Member
  • Posts: 123
Here comes Vir201 !
« on: July 30, 2007, 05:03:31 AM »
MELBOURNE, Australia | July 18, 2007 | Virax Holdings Limited (ASX: VHL) announces that it has received notification that the paper presenting the results of its VIR201 Phase IIa human clinical trial has been accepted for publication in the scientific journal "Human Vaccines"The full paper will appear in the Jan/Feb 2008 edition (Vol 4 Issue 1) of Human Vaccines.

The Abstract of the paper entitled "Influence of IFN? Co-Expression on the Safety and Antiviral Efficacy of Recombinant Fowlpox Virus HIV Therapeutic Vaccines Following Interruption of Antiretroviral Therapy" is available now from the journal's web page at: http://www.landesbioscience.com/journals/vaccine/article/4627

This is the second scientific peer reviewed paper dealing with results from this important VIR201 clinical trial (please note background section below)

Virax is developing VIR201 as a therapeutic vaccine for the treatment of HIV/AIDS. The therapeutic vaccine approach of stimulating the immune system is in contrast with the existing anti-retroviral treatments that directly target the infecting HIV virus.

Worldwide sales of HIV/AIDS therapeutics were US$7.1 billion in 2005 and are expected to reach US$10.6 billion by 2015 (Datamonitor Report, April 2007).

The Phase IIa trial of VIR201, sometimes referred to as the "Extension Study" because it followed on from a Phase I (safety) trial, demonstrated that when compared with placebo, VIR201 was able to suppress reappearance of the HIV virus after anti-retroviral therapy was discontinued. The HIV virus levels in the placebo treated patient group were more than 6 times higher than the VIR201 treated patient group.

Two of the ten patients in the VIR201 arm of the trial had a reduction of 2 logs (a factor of 100) in viral load compared to the placebo arm. In addition two patients out of a number who joined a follow up group had not returned to their anti-retroviral therapy for a total of 200 weeks from the trial start.

The results from these trials have been reviewed and assessed by a number of expert groups including the FDA which has granted VIR201 IND (Investigational New Drug) status for a Phase II trial in the USA at higher dose levels than employed in these initial trials. Nevertheless, publication in a peer reviewed scientific journal is the first public acknowledgement of the quality of these important trial results and further validation of the science underlying the Co-X-Gene(tm) Technology and VIR201
Aug 9, 2006 Get infected in Japan #$%^*
Oct 2006 CD4 239
Nov 2006 CD4 299 VL 60,000
Dec 1, Sustiva, Ziagan and 3TC
Jan 07, CD4 400

Offline NYCguy

  • Member
  • Posts: 180
Re: Here comes Vir201 !
« Reply #1 on: July 30, 2007, 11:34:42 PM »
It does sound interesting and something to follow, albeit pretty cleverly timed to coincide with the IAS conference in Sydney...
11/9/06 = #$%^&!
sometime early Dec 2006:
CD4 530 20%/VL >250,000 (&*$$%!!)
started Reyataz300mg/Norvir/Truvada 12-27-06.
1/30/07 CD4 540 30%/VL <400
4/07 CD4 600+ 33%/VL <50
6/9/07 CD4 720 37%/VL <50
10/15/07 CD4 891 (!) %? VL <50
1/2010 CD4 599 (37%) VL<50 (drop due to acute HCV)
9/2010 - looks like HCV is gone for good! And I'm finally drinking again, thank GOD
2013 - considering a switch to Stribild. but I love my Kidneys (but I hate farting all the time!)...
June 2013 - switched to Stribild.  so far so good...

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.